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The developmentally arrested third stage infective
larva of hookworms resumes development upon entry
into the definitive host. This transition to parasitism
can be modeled in vitro by stimulating infective larvae
with a low molecular weight ultrafiltrate of host serum
together with methylated glutathione analogues. When
stimulated to resume development in vitro, activated
larvae of the hookworm Ancylostoma caninum released
a 42-kDa protein, termed Ancylostoma-secreted protein
(ASP). ASP was the major protein released by activated
hookworm larvae. Degenerate oligonucleotide primers,
based on a partial internal amino acid sequence of the
protein, were used together with flanking vector se-
quence primers to amplify a fragment from a third stage
larval cDNA library by polymerase chain reaction. The
fragment was used as a probe to isolate a longer clone
from the larval cDNA library. The full-length ASP cDNA
was found to encode a 424-amino acid protein with ho-
mology to the antigen 5/antigen 3 family of proteins from
hymenopteran venoms and a family of cysteine-rich se-
cretory proteins. ASP was expressed in bacterial cells,
and a polyclonal antiserum against purified recombi-
nant ASPwas produced. The antiserum, which was dem-
onstrated to be specific for ASP, was used as a probe to
measure the kinetics of ASP release by hookworm lar-
vae. ASP is released within 30 min of stimulation, with
the majority released by 4 h. Low levels of ASP were
released continuously following activation, but only if
the stimuli were present in the incubation medium. The
compound 4,7-phenanthroline, previously shown to in-
hibit larval activation, also inhibited release of ASP. The
specific, rapid release of ASP by activated infective lar-
vae suggests that this molecule occupies a critical and
central role in the transition from the external environ-
ment to parasitism.
The early events of the hookworm infectious process are
poorly understood, especially at the molecular and biochemical
level. A better understanding of the molecules released by
invading larvae, and the host’s responses to them, would allow
for the rational design of immuno- and chemotherapeutic in-
tervention strategies. However, the inability to culture hook-
worms beyond the third-stage larvae (L3)
1 in vitro, together
with the difficulties associated with the isolation of sufficient
parasitic stages for molecular and biochemical studies, has,
until recently, hampered investigations of the critical first
steps in the establishment of the parasitic relationship.
The initial events of the infectious process can now be mod-
eled in vitro, using the resumption of feeding as a marker for
the transition from the free-living L3 to the developing para-
sitic L3 (1–3). When free-living L3 of the canine hookworm
Ancylostoma caninum are stimulated to resume feeding in
vitro, they release several molecules into the culture medium.
Recently, a zinc metalloprotease activity has been reported
from activated A. caninum L3 ES products (4). Here we report
the isolation, cloning, and expression of a 40-kDa protein from
activated ES products, referred to as Ancylostoma-secreted pro-
tein (ASP), that is homologous to the major venom allergen of
hymenopteran insects. ASP is the major protein released by
activated hookworm L3. Its release during invasion of the host,
together with its partial homology to previously described al-
lergens from insect venoms, suggest that it may orchestrate
key events in the patho- and immunobiology of hookworm
infection.
MATERIALS AND METHODS
Larval Activation—A. caninum was maintained as described previ-
ously (3). L3 were collected from 1–4 wk-old coprocultures by the Baer-
mann technique, and decontaminated with 1% HCl in BU buffer (50 mM
Na2HPO4, 22 mM KH2PO4, 70 mM NaCl, pH 6.8) (5) for 30 min at 22 °C.
Approximately 3500–7500 L3 were incubated in individual wells of a
24-well tissue culture plate containing 0.5 ml of RPMI 1640 tissue
culture medium, supplemented with 0.25 mM HEPES, pH 7.2, 100
units/ml penicillin, 100 mg/ml streptomycin, 100 mg/ml gentamicin, and
2.5 mg/ml amphotericin B. The L3 were activated to resume develop-
ment and feeding by including 15% (v/v) of a ,10-kDa ultrafiltrate of
canine serum and 25 mM S-methylglutathione (4). Nonactivated L3
were incubated in RPMI alone (i.e. without the stimulus). The L3 were
incubated at 37 °C, 5% CO2 for 24 h. The percentage of feeding L3 was
determined by incubating aliquots of L3 with 2.5 mg/ml fluorescein
isothiocyanate-labeled bovine serum albumin for 2–3 h, followed by
counting the number of L3 that had ingested the labeled bovine serum
albumin by microscopic examination under epifluorescent illumination
(6).
Collection of ES Products—Medium containing activated larvae was
transferred to individual microcentrifuge tubes and centrifuged for 5
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min at 16,000 rpm. The tubes were placed on ice for 10 min to slow the
swimming motion of the larvae. The supernatant containing the ES
products was carefully transferred to a new microcentrifuge tube, and
inspected visually using a dissection microscope to assure that no L3
had been transferred. Supernatants were pooled and stored at 220 °C.
Prior to electrophoresis, supernatants were concentrated 4–10 times by
lyophilization or ultrafiltration using Centricon 10 cartridges (Amicon,
Beverley, MA).
Protein Sequencing—ES products from approximately 50,000 acti-
vated A. caninum L3 were concentrated and electrophoresed in a 12.5%
acrylamide gel (7) under nondenaturing conditions. The major band of
Mr 5 40,000 was visualized by Coomassie Blue staining and excised.
Approximately 98 pmol of isolated protein were digested with trypsin in
situ as described elsewhere (8, 9). Enzymatic digests were fractionated
by reverse phase HPLC on a Hewlett Packard 1090 HPLC system, and
several peaks were quantified by laser desorption mass spectrometry
prior to sequencing, as described previously (8).
PCR—Degenerate oligonucleotide primers, corresponding to the EP-
DALG portion of protein sequence and synthesized in both orientations,
were used to amplify an ASP gene-specific product from DNA isolated
from an A. caninum L3 cDNA library constructed in lZAP II (Strat-
agene, La Jolla, CA). The preparation of the cDNA library is described
elsewhere (10). The degenerate primers were paired with flanking
vector primers (T3 or T7 promoter) in a PCR. The PCR conditions were
10 mM Tris-HCl (pH 9.0), 50 mM KCl, 0.1% Triton X-100, 1.5 mM MgCl2,
0.2 mM of each dNTP, 1 unit of Taq DNA polymerase (Promega, Mad-
ison, WI), and 75 ng of phage DNA, containing the L3 cDNA library, in
a 20-ml reaction. Preliminary experiments indicated that amplification
using the sense strand degenerate primer ASP-5 (Table I) and the T7
primer produced a 550-bp product. Ten identical reactions containing
only the DNA and primers in 10 ml were subjected to “hot start” PCR
(11). The reactions were heated at 94 °C for 5 min, then lowered to 85 °C
for 5 min, during which time the remaining reaction components were
added. This was followed by 30 cycles of 1 min of denaturation at 94 °C,
1 min of annealing at 45 °C, and 2 min of extension at 72 °C. The PCR
reactions were pooled, digested with PstI and KpnI, and separated by
electrophoresis in a 3% low melting point NuSieve GTG agarose gel
(FMC Bioproducts, Rockland, ME) containing 0.5 mg/ml ethidium bro-
mide. The 550-bp band was excised, transferred to a microcentrifuge
tube, and melted at 65 °C. The melted agarose was frozen in a dry
ice-ethanol bath and immediately centrifuged at 16,000 3 g for 10 min.
The aqueous phase was transferred to a new tube, ethanol-precipitated,
resuspended in 7 ml of distilled H2O, and cloned into pBluescript by
standard methods. Double-stranded plasmid DNA was sequenced by
the dideoxy method (12, 13), using the Sequenase 2.0 kit (U.S. Biochem-
ical-Amersham Corp, Cleveland, OH) and sequential synthetic oligonu-
cleotide primers.
Library Screening—The A. caninum L3 cDNA library was propa-
gated in XL1-BLUE cells, and plated according to standard methods
(14). Approximately 2 3 105 plaques were screened with an RNA probe
made by transcription of linearized pBluescript containing the 550 bp of
PCR product with T3 RNA polymerase (Boehringer Mannheim) in the
presence of a-[32P]UTP. Hybridization conditions were as follows: 6 3
SSPE (1 3 SSPE 5 150 mM NaCl, 10 mM NaH2PO4, 1 mM EDTA), 10 3
Denhardt’s solution (1 3 5 0.02% bovine serum albumin, 0.02% poly-
vinylpyrrolidone, 0.02% Ficoll 400), 1.0% SDS, 200 mg/ml yeast tRNA,
50% formamide, and the radiolabeled probe ('1.2 3 106 cpm/ml) at
42 °C for 18 h. Filters were washed with 2 3 SSC, 0.1% SDS at 60 °C for
45 min, 0.2 3 SSC, 0.1% SDS at 60 °C for 30 min, and 0.1 3 SSC, 0.1%
SDS at 60 °C for 60 min (1 3 SSC 5 150 mM NaCl, 15 mM sodium
citrate), and exposed to XAR-5 film (Eastman Kodak Co.) with an
intensifying screen for 7 h at 270 °C. Two rounds of plaque purification
resulted in eight clones, which were rescued by in vivo excision of their
plasmid DNAs (15). Plasmid DNAs (pBluescript) were isolated by
standard procedures, and digested with EcoRI and XhoI to release the
inserts. Two of the eight inserts were of different sizes, of approximately
1000 and 1200 bp. The 59 and 39 ends were sequenced using T3 and T7
primers, respectively. Both clones had 39-poly(A) tails and identical 39
sequences. The 59 ends were different, but further sequencing indicated
that the shorter clone was a truncated version of the longer clone,
renamed pASP-1. Restriction mapping indicated internal EcoRI and
NcoI restriction sites (Fig. 1), which were utilized for subcloning to
facilitate sequencing. Both strands were sequenced completely.
59-RACE—A modified 59-RACE technique was used to isolate the 59
end and start codon of the ASP cDNA (16–18). Approximately 400 mg
of frozen A. caninum L3 were ground to a powder in a mortar chilled in
liquid nitrogen, and total RNA isolated using the TRIzol reagent (Life
Technologies, Inc.). First strand cDNA was synthesized from total RNA
using Moloney murine leukemia virus reverse transcriptase (Super-
script II, Life Technologies, Inc.) and 1 pmol of ASP gene-specific primer
1 (GSP-1) (Fig. 1 and Table I) according to the manufacturer’s protocol.
The cDNA was ethanol precipitated in the presence of 10 mg of yeast
tRNA and resuspended in 200 ml of distilled H2O. A poly(dG) tail was
added to the 39 end of the cDNA using terminal deoxytransferase. A
50-ml reaction containing 33.5 ml of cDNA, 1 mM dGTP, and 15 units of
terminal deoxytransferase (Life Technologies, Inc.) was incubated for 1
h at 37 °C. Following tailing, the reaction was extracted once with
phenol:chloroform:isoamyl alcohol (25:24:1), ethanol-precipitated, and
resuspended in 150 ml of distilled H2O. Two ml were used as template
for the first PCR reaction, containing 25 pmol of GSP 2 antisense
primer, located internally to the primer used for RT (Fig. 1 and Table I),
together with 25 pmol of a 59-poly(G) anchor primer (Fig. 1 and Table I).
The 50-ml reaction was subjected to 40 cycles of 1 min at 94 °C, 1 min at
48 °C, and 1 min at 72 °C. Following amplification, 1 ml of the reaction
was used in a second PCR reaction, which was identical to the first,
except that a third nested antisense primer, GSP-3 (Fig. 1 and Table I)
with a 59-EcoRI restriction site, was substituted for GSP-2, and the
annealing temperature increased to 55 °C. Four reactions were pooled,
extracted with phenol and chloroform, ethanol-precipitated, and di-
gested with BamHI and EcoRI. The inserts were gel purified, cloned
into pBluescript, and sequenced as above.
Computer Analysis—Sequence editing, alignments, and comparisons
were performed using the Wisconsin Genetics Software Package (Ge-
netics Computer Group, Madison, WI) on a VAX 7610 computer. The
potential signal sequence cleavage sites was determined using the
PSIGNAL program (PC/GENE Release 5.18, Intelligenetics, Mountain
View, CA) on a personal computer.
Expression and Purification of Recombinant ASP—A 1-kb EcoRI/
XhoI fragment containing the 39 end and poly(A) tail of ASP-1 (Fig. 1)
was cloned in-frame into the pET28(c) expression vector (Novagen,
Madison, WI) and used to transform competent BL21 Escherichia coli




B) gal dcm). Log-phase cells were induced
by the addition of 1 mM isopropyl-1-thio-b-D-galactopyranoside and
incubated for 3 h at 30 °C. One-ml aliquots were removed at 0, 1, 2, and
3 h of induction and examined by SDS-PAGE (7) and Western blotting
(see below).
For purification of rASP, a 2-liter culture of BL21 cells containing the
recombinant plasmid pET28:ASP was induced as described above. The
cells were centrifuged, the pellet resuspended in 60 ml of 50 mM Tris
(pH 8.0), 2 mM EDTA, 0.1% Triton X-100, 6 mg of lysozyme, and
incubated at 30 °C for 30 min. The solution was sonicated using a
Branson 450 Sonifier (30% duty cycle, output setting 3) until it was no
longer viscous and centrifuged at 12,000 3 g for 15 min. The pellet was
resuspended in 60 ml of 1.0% SDS, 0.5% 2-mercaptoethanol, boiled for
5 min, and cooled to 22 °C. The extract was dialyzed (Mr 5 12,000–
14,000) against 2 liters of 0.1% SDS in phosphate-buffered saline for 2
days at 22 °C, with two changes of buffer. The cell extract was applied
to a 10-ml HisBind resin column (Novagen), and chromatography was
conducted according to the manufacturer’s instruction, except that 0.1%
SDS was added to all buffers. The expressed protein, containing a
6-residue histidine tag (His-Tag, Novagen) that bound it to the Ni1
resin, was eluted from the column with 0.1–1.0 M stepwise gradient of
imidazole, dialyzed as above, and isolated by preparative SDS-PAGE on
11% acrylamide gels.
Antisera Production—rASP antiserum was produced by immuniza-
tion of a New Zealand White rabbit with gel-purified rASP. The gel
slices were macerated and injected subcutaneously with complete
Freund’s adjuvant. Additional boosts with purified rASP in incomplete
Freimd’s adjuvant were administered at 3, 6, and 9 weeks. Vesq Ag5
antiserum was produced by immunization of a New Zealand White
rabbit with purified Vespula squamosa Ag5 (Vesq Ag5) in complete
Freund’s adjuvant in multiple intradermal sites (19). The antigen was
estimated to be over 98% pure by SDS-PAGE and protein sequence
analysis (20).
TABLE I
Primers used for cloning and 59-RACE
R 5 A or G; Y 5 C or T; N 5 A, C, T, or G. Restriction sites PstI
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Specificity of the antisera was confirmed by its adsorption with
purified rASP. rASP was coupled to 3 M Emphaze beads (Pierce, Rock-
ford, IL) by incubating 0.2 g of beads with 0.27 mg of rASP in phos-
phate-buffered saline, 0.1% SDS, 0.8 M sodium citrate, pH 8.0, over-
night at 22 °C. The beads were sedimented by gentle centrifugation, the
supernatant was discarded, and the coupling reaction was stopped by
adding 10 ml of 1.0 M Tris, pH 8.0, followed by incubation at 22 °C for
2.5 h. The beads were washed twice with phosphate-buffered saline and
stored at 4 °C. rASP antiserum (1:500) and Vesq Ag5 antiserum (1:
2000) were diluted in 5% NFDM-P, and 10 ml were incubated with 0.2
ml of ASP-conjugated beads overnight at 4 °C. The beads were removed
by centrifugation, and the supernatant was used in a Western blot (see
below).
Western Blotting—Concentrated ES products or rASP were sepa-
rated in 11% SDS-polyacrylamide gels and transferred to Immobilon-P
poly(vinylidene fluoride) membranes (Millipore, Bedford, MA) by elec-
troblotting at 20 V for 16–18 h at 4 °C (21). The membranes were
blocked with 5% NFDM-P for 6–8 h at 4 °C. Following blocking, the
membrane was incubated with a 1:2000 dilution of rabbit anti-Vesq Ag5
antiserum or a 1:500 dilution of rabbit anti-rASP antiserum in
NFDM-P for 16–18 h at 4 °C. After three washes in NFDM-P, the
membrane was incubated with a 1:5000 dilution of horseradish perox-
idase-conjugated goat anti-rabbit IgG secondary antibody (Sigma) for 1
h at 22 °C. Bands were visualized using enhanced chemiluminescence
(Amersham Corp.).
In Vitro Activation Experiments—In vitro activation experiments
were conducted to determine the kinetics of ASP release. In these
experiments, the presence of ASP in ES products was determined by
Western blotting using rASP antiserum as a specific probe. To deter-
mine when ASP is first released by activated L3, individual wells
containing approximately 6000 activated L3 were harvested at 30 min
and 1, 4, and 24 h of incubation, and the ES products were removed and
concentrated by ultrafiltration. Nonactivated L3 incubated for 24 h in
RPMI alone were used as a negative control. The percentage of feeding
L3 in the population was determined at 24 h.
To determine if ASP was released continuously during the activation
process, the ES products of a single population of L3 were sampled over
time. A well containing approximately 6500 L3 was incubated under
standard activation conditions. At 1, 4, and 24 h of incubation, the L3
were removed and pelleted by centrifugation, and the supernatant was
transferred to a new tube and concentrated by ultrafiltration. The L3
were washed three times with 15 ml of RPMI and returned to a new
well. Fresh medium containing the stimuli was added, and the incuba-
tion was resumed, except at 24 h, which was the terminal time point. A
negative control (no stimuli) and a positive control (entire 24-h acti-
vated L3 ES product output) were harvested at 24 h. The percentage of
feeding L3 was determined at 24 h.
To determine whether the presence of the stimulus was required for
continuous ASP release, two wells containing 6000 L3 were incubated
with the stimulus for 1 or 4 h. At these times, the ES products were
harvested, and the L3 were washed three times with RPMI and rein-
cubated in RPMI alone (i.e. without the activation stimuli). At 24 h, the
ES products were harvested again, and the percentage of feeding L3 was
determined. Activated and nonactivated larvae incubated for 24 h were
used as controls, with their ES products collected at 24 h only.
4,7-Phenanthroline, a known feeding inhibitor (4), was tested for its
effect on ASP release. Approximately 6000 L3 were incubated with 0.5
mM 4,7-phenanthroline and activation stimuli for 24 h. Following incu-
bation, the ES products were harvested and concentrated by ultrafil-
tration. The ES products from all experiments were examined by West-
ern blotting using rASP antiserum as described above.
Image Analysis—Autoradiographs of Western blots were scanned
using a HP Scanjet IIcx digital scanner (Hewlett-Packard, Corvallis,
OR) using HP DeskScan version 2.0 software on a Power Mac 6100
(Apple Computers, Cupertino, CA). The image was saved as a TIF file,
and analyzed using NIH Image software version 1.54 (Wayne Rasband,
NIH). Areas of the bands were selected by drawing a rectangle around
the band. An area of identical size, to be used as a measure of the
background level, was selected from the negative control lane at the
same position as the positive bands. Therefore, values are expressed
relative to the negative control, which although not visible, might
register in the scan. Total intensity of the area was calculated by NIH
Image, the background value was subtracted, and the corrected pd was
used for comparisons.
RESULTS
When A. caninum L3 are stimulated to resume feeding in
vitro, they release a major product of approximately Mr 5
40,000, referred to as ASP. In contrast, no proteins are detected
in the ES products of nonactivated L3 (not shown). Microse-
quencing of a trypsin digestion product of this protein revealed
a peptide with the sequence GLEPDALGGNAPK. A degener-
ate primer derived from the EPDALG portion of this sequence,
together with a primer complementary to flanking vector se-
quence, amplified a fragment of approximately 550 bp from
phage l DNA containing an A. caninum L3 cDNA library. This
product was used as a probe to isolate a 1.2-kb cDNA clone
encoding ASP from the A. caninum L3 cDNA library. The cDNA
contained a 39 poly(A) tail, but lacked a 59 initiation codon. The
59 end containing the ATG (Met) start codon was isolated from
L3 cDNA by 59-RACE (16–18). Four 59 end clones were se-
quenced, and found to encode identical sequences that were in
frame with and overlapped the cDNA clone. Unlike another
hookworm cDNA recently cloned in our laboratory (10), none of
the 59 sequences contained the conserved nematode SL 1 or SL
2 (22–24), nor could the 59 end be amplified from cDNA using
SL 1 primer and an internal gene-specific primer.
The full-length cDNA encodes an ORF of 424 amino acids,
with a predicted molecular weight of 45,735, a pI of 7.13, and a
FIG. 1. The complete DNA and deduced amino acid sequence
of the ASP cDNA. The sequenced peptide (amino acids 255–267) from
which PCR primers were derived is in bold type, and the sequence of the
primer used for PCR is double overlined. The location of primers used
for 59 RACE are overlined, and the restriction enzyme sites EcoRI and
NcoI used for subcloning are underlined. The 18-amino acid secretory
signal sequence (amino acids 1–18) is in bold italic type. The complete
cDNA sequence was submitted to GenBankTM with the accession no.
U26187.
Ancylostoma-secreted Protein of Activated Hookworm Larvae6674
34-bp 39-untranslated region (Fig. 1). The entire sequence of
the original peptide purified from ES products was present in
the ORF (amino acids 255–267), confirming that this cDNA
encodes the ASP molecule. The amino-terminal 18 amino acids
are highly hydrophobic (11/18), and a potential eukaryotic sig-
nal sequence cleavage site is located between amino acids 18
(A) and 19 (S) (25), consistent with the secretory nature of the
protein. There are no N-linked glycosylation sites present in
the ORF.
Data base comparison (SwissProt) revealed significant ho-
mology between the COOH-terminal 215 amino acids of the
ASP-deduced amino acid sequence and the antigen 5/antigen 3
family of molecules from Hymenoptera venoms (26–28), a fam-
ily of cysteine-rich secretory proteins, called CRISPs (29–34),
and pathogenesis-related proteins in plants (35) (Fig. 2). The
amino-terminal 191 amino acids failed to show significant ho-
mology to any proteins in the data base. Because of the appar-
ent homology to hymenopteran venom Ag 5, a polyclonal anti-
serum against Vesq Ag5 was tested for its ability to recognize
secreted and recombinant ASP. As shown in Fig. 3b, Vesq Ag5
antiserum cross-reacted with both the recombinant and native
ASP molecules, although recognition was not entirely specific.
In addition to ASP, the heterologous serum also recognized a
protein of Mr ' 28,000 in ES products from activated L3. The
antiserum also cross-reacted with rASP, as well as a higher
molecular weight protein. However, adsorption of the Vesq Ag5
antiserum with rASP removed all reactivity with the ES prod-
ucts, and decreased binding to rASP by 78%, in addition to
abrogating the high Mr reactivity in the rASP lane. The Vesq
Ag5 antiserum failed to recognize any proteins in the ES prod-
ucts from nonactivated L3.
In contrast, the rabbit antiserum prepared against purified
rASP exclusively recognized both the recombinant and the
native molecules. As seen in the Western blot in Fig. 3a, the
antiserum recognized a band of Mr ' 40,000–42,000 in ES
products from activated L3, and a slightly lower Mr band in
purified rASP, but nothing in the ES products from nonacti-
vated L3. Adsorption of the antiserum with rASP completely
abrogated the reaction (Fig. 3a), indicating that the antiserum
was specific for ASP.
The rASP antiserum was used investigate the kinetics and
biology of ASP release. The first experiment was designed to
determine when ASP is first released by activated L3. ES
products were collected at several time points, and analyzed by
Western blotting with rASP antiserum as the probe. Infective
L3 released ASP as early as 30 min following exposure to
activating stimuli (Fig. 4). Image analysis indicated that by 4 h,
ASP release had reached levels equal to that released by 24 h
in the positive control (pd at 4 h 5 118, 24 h 5 116).
A second experiment was conducted to determine whether
ASP was released continuously during the incubation, or
whether it was primarily released early in the activation proc-
ess. In this experiment, ES products were harvested from a
single population of activated L3 at several time points. The ES
products were first harvested at 1 h, and the L3 were thor-
oughly washed and returned to the tissue culture plate with
fresh medium containing the activation stimuli. This was re-
peated on the same population of L3 at 4 h. At 24 h, the ES
products were collected, and the L3 were assayed for feeding.
Therefore, the ES products contained the ASP secreted be-
tween 0 and 1 h of incubation, 1–4 h of incubation, and 4–24 h
of incubation. As shown in Fig. 5, ASP was present in the ES
FIG. 2. Comparison of the ASP deduced amino acid sequence with the amino acid sequences of selected homologous molecules.
Shaded residues are identical to those in ASP, and positions marked with an asterisk (*) are conserved in all molecules. Numbers in parentheses
represent the percent identity with ASP, calculated using pairwise comparisons between ASP and the homolog using the GAP program of the
Wisconsin Genetics program. Solin, antigen 3 from the red imported fire ant, Solenopsis invicta (accession no. P35778); Vessq, Vesq Ag5 from the
yellow jacket V. squamosa (P35786); Htpx, human testes-specific protein (B33329); Rscg, rat sperm-coating glycoprotein (acidic epididymal
glycoprotein, A24609); Helo, helothermine from Mexican beaded lizard (Heloderma horridum horridum) salivary gland (U13619); Pr1a, tobacco
pathogenesis-related protein 1a precursor (S00513).
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products from all time intervals, although the 0–1 h fraction
contained more than the other time intervals. Comparison of
the 0–1 h band (lane 2, pd 5 65.4) with the total ASP released
(lanes 2–4, total pd 5 111) by image analysis indicated that
nearly 60% of the total ASP released over 24 h was released in
the 1st h following exposure to stimuli. Furthermore, almost
90% of the total ASP is released by 4 h (sum of lanes 2–3, pd 5
98.9, versus lanes 2–4). The number of the manipulated L3 that
were feeding at 24 h was similar to the percentage of undis-
turbed, activated L3 that fed (88 versus 95%), indicating that
the larvae suffered no untoward effects during harvesting of
the ES products.
A third experiment was designed to determine if ASP release
was dependent on the presence of the activation stimuli. In this
experiment, ES products were harvested from individual pop-
ulations of L3 at either 1 or 4 h of incubation, and the L3 were
washed and reincubated in the absence of stimuli. The ES
products from the reincubated L3 were harvested at 24 h and
examined by Western blot with rASP antiserum. As seen in
Fig. 6, rASP antiserum recognized strong bands in the 1-, 4-,
and 24-h (positive control) ES products. However, no further
ASP was released when the ES products from L3 reincubated
without the stimuli were examined at 24 h, despite the fact that
significant proportions of the L3 had been triggered to resume
feeding when assayed at 24 h (1 h, 51% feeding; 4 h, 68%; 24-h
control, 87%).
Inclusion of 2.5 mM 4,7-phenanthroline in the incubation
decreased ASP release by 58% (Fig. 7, uninhibited pd 5 106.8,
inhibited pd 5 45.3). Feeding was decreased from 96% in un-
inhibited L3 to 13% in L3 exposed to the inhibitor.
DISCUSSION
During invasion of a definitive host, hookworm infective L3
encounter signals that initiate developmental pathways that
were previously suspended in the free-living L3 stage (2, 36,
37). The resumption of feeding by parasitic L3 associated with
exposure to hostlike conditions functions as a marker for acti-
vation and the transition to parasitism (2, 3). Coincident with
in vitro activation, L3 release a 40-kDa molecule, known as
ASP, as the major component of ES products. In order to
investigate its role in the transition to parasitism, the cDNA
encoding ASP was cloned and analyzed. The cloned molecule
was expressed in E. coli cells, purified, and used to produce a
polyclonal antiserum.
Sequencing of the ASP cDNA revealed an open reading
frame of 424 amino acids. The 59 end of the cDNA encoded a
highly hydrophobic (11/18) amino acid NH2 terminus. The pres-
ence of a probable cleavage site (25) between Ala-18 and Ser-19
suggests that the 18 NH2-terminal amino acids represent the
signal peptide that targets ASP as a secretory protein. The
calculated molecular mass of the complete peptide encoded by
the ORF is 45,735 daltons, whereas the calculated molecular
mass of the protein without the signal sequence is 43,793
daltons, which agrees more closely with the apparent Mr of
FIG. 3. Adsorption of antisera with rASP. Concentrated ES prod-
ucts from 6000 nonactivated (NA) or activated (ACT) A. caninum L3,
together with 8 mg of purified rASP, were separated in an 11% poly-
acrylamide gel. Following transfer to poly(vinylidene fluoride) mem-
branes, the blots were probed with neat antiserum or antiserum ad-
sorbed against rASP. a, anti-rASP antiserum, 1:500; b, anti-Vesq Ag5
antiserum, 1:2000.
FIG. 4. Time course of ASP release. Western blots containing ES
products from 6000 activated A. caninum L3 were probed with rASP
antiserum (1:500). Lane 1, nonactivated L3, 24 h of incubation; lane 2,
30 min of incubation; lane 3, 1 h of incubation; lane 4, 4 h of incubation;
lane 5, 24 h of incubation.
FIG. 5. Kinetics of ASP release by a single population of A.
caninum L3. ES products from 6500 L3 were collected at various time
points, the L3 were washed, and the incubation was continued in the
presence of activation stimuli. Lane 1, nonactivated L3, 24 h of incuba-
tion (negative control); lane 2, ES products harvested at 1 h of incuba-
tion (0–1-h output); lane 3, ES products harvested at 4 h of incubation
(1–4-h output); lane 4, ES products harvested at 24 h of incubation
(4–24-h output); lane 5, ES products incubated for 24 h (0–24-h output,
positive control).
FIG. 6. Continuous ASP release requires the stimulus. ES prod-
ucts were harvested at specified times, the L3 were washed, and incu-
bation was continued in the absence of the activation stimuli. ES
products were examined by Western blotting. Numbers in parentheses
indicate percentage feeding when assayed at 24 h. Lane 1, ES products
from nonactivated L3 incubated for 24 h; lane 2, activated L3 ES prod-
ucts incubated 24 h; lane 3, activated L3 ES products, 0–1-h output;
lane 4, activated L3 ES products, 1–24 h without stimulus; lane 5,
activated L3 ES products, 0–4-h output; lane 6, activated L3 ES prod-
ucts, 4–24 h without stimulus.
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ASP in ES products ('40,000–42,000) determined by gel elec-
trophoresis (Fig. 3). Comparison of the ASP predicted amino
acid sequence to protein data bases revealed significant homol-
ogy ('50–56% similarity, '30–35% identity) between the car-
boxyl-terminal 230 amino acids of ASP and the Ag 3/Ag 5
proteins of hymenopteran venoms (Fig. 2). Venom Ag5 is the
major protein of several hymenopteran venoms and as such
represents the major antigen (38). Its function is unknown,
although it has been hypothesized to be an invertebrate
neurotoxin (39).
The homology to venom proteins was confirmed by the ability
of antiserum directed against Ag 5 of the yellow jacket V.
squamosa to recognize ASP on Western blots of ES products
and expressed rASP (Fig. 3b). The Vesq Ag5 antiserum also
recognized a protein of lowerMr in ES products from activated
L3 that is not recognized by the rASP antiserum. Amino acid
sequencing indicated that this lower Mr component is closely
related to ASP (not shown) and probably represents another
member of a family of ASP-like secretory proteins. This is
supported by the elimination of cross-reactivity by adsorption
of the antiserum with rASP, indicating that the low Mr mole-
cule contains an epitope that is recognized by the polyclonal
Vesq Ag5 antiserum, but not by the rASP antiserum.
ASP is also homologous to a family of CRISPs isolated from
testis (mouse and human TPX-1, 29.7 and 37.7% identity;
mouse CRISP-1, 31.7%) and salivary glands of mice (CRISP-3,
29.1%) and beaded lizards (helothermine, 33.5%) (29–34). The
latter peptide is a salivary toxin that inhibits Ca21-induced
Ca21 release by blocking the ryanodine receptor on the sarco-
plasmic reticulum. ASP contains 7 of the 16 invariant cysteine
residues, but less than half of the cysteine-rich COOH-terminal
domain, that are hallmarks of the CRISP family of proteins.
However, all of the molecules, including ASP and the insect
venoms, share a common sequence (HYTQ) corresponding to
amino acids 358–361 of ASP (31).
ASP release occurs rapidly in the activation process, with
large amounts secreted within 30 min of exposure to the acti-
vation stimuli. Nearly all of the total ASP secreted is released
by 4 h of incubation. These data suggest that ASP might be
produced and stored in secretory granules that are released in
response to activation, as occurs during activation and molting
of other parasitic nematodes (37). Indeed, isolation of the ASP
message from a cDNA library of nonactivated L3 indicates that
mRNA-encoding ASP is present in the free-living stage prior to
activation. However, it is possible that ASP mRNA is masked
and translated only in response to the activation signal. Also,
there is a low level of stimulus-dependent ASP released be-
tween 4 and 24 h, suggesting new, activation-associated syn-
thesis of ASP. One possible explanation is that the activation
stimulus causes the release of stored ASP from secretory gran-
ules, but also initiates ASP gene expression, resulting in con-
tinued low levels of ASP production and release. Confirmation
of this hypothesis awaits the results of more detailed analysis
of ASP stage-specific expression and ASP immunolocalization
experiments.
ASP release occurs much earlier than the resumption of
feeding, which typically begins at 6–8 h (6). Although feeding
and ASP release both occur following exposure to the activation
stimulus, the two events differ in that, once initiated, the
presence of the stimulus is not required for feeding to continue
(6), whereas the stimulus is required for continuous release of
ASP. Studies are underway to determine whether ASP secre-
tion can be uncoupled from feeding, or whether both phenom-
ena occur in response to the same stimuli.
The rapid and constitutive release of ASP suggests an im-
portant function early in the infective process, perhaps as a
modulator of the host immune response. There are numerous
reports of ES products from nematode parasitic stages that
alter host physiology or suppress host immunity, either by
inhibiting immune effector mechanisms (40, 41) or by direct
immunosuppression (42–44). Recently, adult A. caninum were
shown to secrete a neutrophil inhibitory factor that binds to
CD11/CD18 receptor of neutrophils and inhibits their ability to
mediate phagocytosis (45, 46). Sequence comparison indicated
that there is a 30.7% identity between ASP and neutrophil
inhibitory factor (not shown). Thus, ASP might serve a similar
function in pre-adult parasitic stages, thereby allowing invad-
ing L3 to interfere with the host inflammatory response and
evade destruction. Because ASP also exhibits homology with
the peptide toxin helothermine (33.5% identity) (31), it is also
possible that ASP exerts a direct toxic effect on host immune
effector cells.
Alternatively, because of its close homology to Vesq Ag5, ASP
might function as an allergen. Allergens elicit immediate-type
hypersensitivity inflammatory host responses comprised of IgE
production and a so called TH2 cytokine profile, including IL-4,
Il-5, and Il-10. It is of interest that intestinal nematode infec-
tions also bias the host inflammatory response to produce Il-4
and Il-5 for the stimulation of IgE production and eosinophilia,
respectively (47). Studies are underway to determine whether
the TH2-like responses found in hookworm infection might
arise in response to ASP.
Determination of the actual in vivo function of ASP will
require further investigation. However, because its release co-
incides with infection and the transition to parasitism, ASP is
a promising candidate for a recombinant vaccine against hook-
worm disease. ES products of several nematodes elicit some
degree of host protection when used as vaccine antigens (40,
48–52). The only successful hookworm vaccine to date, against
canine hookworm, employed radiation-attenuated infective L3,
and although a commercial failure, did reduce worm burden
and the resultant pathology (53). One possibility is that the
immune response against the irradiated L3 was directed
against an ES product, perhaps ASP, released during invasion.
Evaluation of ASP as a vaccine candidate is currently under
way.
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